Total Payments
$3,401
2024 Payments
$787.71
Companies
33
Transactions
191
Medicare Patients
1,884
Medicare Billing
$267,506
Payment Breakdown by Category
Food & Beverage$3,401 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,401 | 191 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $578.81 | 38 | $0 (2024) |
| PFIZER INC. | $314.27 | 21 | $0 (2024) |
| Lilly USA, LLC | $260.93 | 14 | $0 (2024) |
| UCB, Inc. | $214.56 | 10 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $197.12 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $192.71 | 12 | $0 (2022) |
| EMD Serono, Inc. | $189.69 | 9 | $0 (2024) |
| Allergan, Inc. | $183.87 | 9 | $0 (2022) |
| Amgen Inc. | $167.53 | 9 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $166.28 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $787.71 | 46 | ABBVIE INC. ($272.22) |
| 2023 | $695.64 | 38 | Sumitomo Pharma America, Inc. ($174.05) |
| 2022 | $705.50 | 40 | ABBVIE INC. ($156.65) |
| 2021 | $252.12 | 13 | AbbVie Inc. ($119.14) |
| 2020 | $126.46 | 8 | Novartis Pharmaceuticals Corporation ($67.34) |
| 2019 | $188.83 | 10 | Novartis Pharmaceuticals Corporation ($44.55) |
| 2018 | $323.25 | 17 | UCB, Inc. ($115.51) |
| 2017 | $321.46 | 19 | Teva Pharmaceuticals USA, Inc. ($112.44) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.69 | General |
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| 11/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: EPILEPSY | ||||||
| 10/31/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: PAIN | ||||||
| 10/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: AMANTADINE | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Neurology | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $0.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Neurology | ||||||
| 07/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| 07/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Neurology | ||||||
| 06/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Central Nervous System | ||||||
| 06/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| 05/31/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 382 | 624 | $119,255 | $60,141 |
| 2022 | 4 | 392 | 663 | $126,166 | $65,096 |
| 2021 | 4 | 556 | 884 | $148,168 | $72,918 |
| 2020 | 4 | 554 | 873 | $158,003 | $69,351 |
Total Patients
1,884
Total Services
3,044
Medicare Billing
$267,506
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 517 | $90,475 | $46,214 | 51.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $21,080 | $10,546 | 50.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $7,700 | $3,381 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 525 | $91,875 | $48,667 | 53.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 83 | 83 | $20,584 | $10,406 | 50.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $11,200 | $5,281 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 23 | $2,507 | $742.68 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 467 | $81,652 | $41,446 | 50.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 115 | 115 | $28,353 | $14,223 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 190 | 280 | $30,462 | $13,624 | 44.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $7,700 | $3,626 | 47.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 285 | 578 | $101,150 | $43,229 | 42.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 117 | 117 | $29,016 | $14,310 | 49.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 117 | 143 | $15,587 | $7,670 | 49.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 35 | 35 | $12,250 | $4,142 | 33.8% |
About Dr. Keith Brecher, MD
Dr. Keith Brecher, MD is a Neurology healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568457323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Brecher, MD has received a total of $3,401 in payments from pharmaceutical and medical device companies, with $787.71 received in 2024. These payments were reported across 191 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,401).
As a Medicare-enrolled provider, Brecher has provided services to 1,884 Medicare beneficiaries, totaling 3,044 services with total Medicare billing of $267,506. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Warwick, RI
- Active Since 09/16/2005
- Last Updated 06/03/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1568457323
Products in Payments
- UBRELVY (Drug) $241.27
- QULIPTA (Drug) $228.81
- BOTOX (Biological) $222.51
- EMGALITY (Drug) $212.59
- NURTEC ODT (Drug) $197.14
- APTIOM (Drug) $197.12
- MAYZENT (Drug) $192.71
- Briviact (Drug) $163.00
- Aimovig (Biological) $134.92
- COPAXONE (Drug) $122.93
- Fycompa (Drug) $79.45
- ACTHAR (Biological) $70.95
- ULTOMIRIS (Biological) $62.97
- MAVENCLAD (Drug) $59.43
- Sunosi (Drug) $56.53
- LYRICA (Drug) $55.83
- TROKENDI XR (Drug) $52.88
- Nayzilam (Drug) $51.56
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $50.66
- AMYVID (Drug) $48.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Warwick
Dr. Thomas Raimondo, Do, DO
Neurology — Payments: $7,592
Neurology $7,592
Dr. Adam Drobnis, Md, MD
Neurology — Payments: $2,373
Neurology $2,373
Neil Labove, M.d, M.D
Neurology — Payments: $1,316
Neurology $1,316
Dr. John Ferro, M.d, M.D
Neurology — Payments: $315.16
Neurology $315.16
Dr. Mauricio Villamar Davila, M.d, M.D
Neurology — Payments: $127.18
Neurology $127.18
Marjorie Smith, Md, MD
Neurology
Neurology